Peptide-Conjugated Quantum Dots Act as the Target Marker for Human Pancreatic Carcinoma Cells

Peptide-Conjugated Quantum Dots Act as the Target Marker for Human Pancreatic Carcinoma Cells

Background/Aims: In the present study, we describe a novel and straightforward approach to produce a cyclic- arginine-glycine-aspartic (RGD)-peptide-conjugated quantum dot (QD) probe as an ideal target tumor biomarker. Due to its specific structure, the probe can be used for targeted imaging of panc...

Full description

Bibliographic Details
Main Authors: Shuang-ling Li, Jing Yang, Xiao-fei Lei, Jian-na Zhang, Hong-li Yang, Kun Li, Chang-qing Xu
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2016-03-01
Series:Cellular Physiology and Biochemistry
Subjects:
Nanotechnology
Quantum dots
Cyclic RGD
Targeted marking
Biocompatibility
Online Access:http://www.karger.com/Article/FullText/443062

Similar Items

Similar Items